Tom Coburn, an ultraconservative Oklahoma Republican and family physician who in 16 years in Congress crusaded for limited government, using a rule-book technicality to block so many bills that frustrated legislators called him Dr. No, died on Saturday in Tulsa. He was 72.
The cause was cancer, said John Hart, his former communications director. Mr. Coburn had said in 2013 that he was being treated for a recurrence of prostate cancer, and in 2014 he announced that he would retire.
Mr. Coburn was an obstetrician who treated some 15,000 patients and delivered 4,000 babies in a maternal and family practice in Muskogee, Okla., before embarking on his political career three terms in the House of Representatives (1995-2001) and, after a four-year hiatus, two terms in the Senate (2005-15). He retired two years before the end of his second term because of deteriorating health.
A visceral foe of Washington long before such disaffections coalesced into the Tea Party, Mr. Coburn swept into Congress with the class of 1994, when Republicans gained control of the House for the first time in 40 years and installed Newt Gingrich as speaker and his Contract With America agenda to shrink government, cut taxes and promote welfare reforms and business activity.
Mr. Coburn soon set about displeasing everyone, including the constituencies most politicians covet: his own partys activists, donors, leaders and congressional colleagues. He battled with Mr. Gingrich often, charging that he was drifting to the political center and away from his contractual pledges to the nation. He openly vented his disdain for career politicians.
His contempt for them is genuine, bipartisan and in many cases mutual, The New York Times reported years later. He once prescribed a spinal transplant for 70 percent of the Senate, and another time said his colleagues had reproductive organs the size of BBs.
As if separating himself from the pack, Mr. Coburn continued to deliver babies as a member of the House. (He gave up his obstetric moonlighting only after a dispute with ethics officials when he entered the Senate.) But he won grudging respect as a political maverick and was admired by some colleagues as one of the toughest fiscal and social conservatives of his era.
For the sake of smaller government, he voted against nearly all spending bills, particularly pork-barrel allocations for the pet projects of legislators. He opposed gay rights, same-sex marriage, embryonic stem-cell research and abortions except those to save a womans life. He denied that global warming was real. He favored term limits for elected officials and pledged to abide by them himself.
In the House, he supported gun rights and favored the death penalty, even for doctors who performed abortions. He also wrote laws aimed at protecting infants from AIDS and expanding medical care for the elderly. He helped reform welfare and other federal entitlement programs, and led workshops for young staff members on sexually transmitted H.I.V. infections.
He caused a stir in 1997 when he protested NBCs decision to televise, in prime time and without editing, Schindlers List, Steven Spielbergs Oscar-winning Holocaust film. He called it televisions all-time low, with full-frontal nudity, violence and profanity, adding, I cringe when I realize that there were children all across this nation watching this program.
He was heavily criticized, including by the American Jewish Congress, which said: This isnt Melrose Place, Mr. Coburn. This is the Holocaust. He apologized to all those I have offended, but insisted that the film should have been aired later in the evening.
Keeping his campaign pledge to serve no more than three consecutive terms in the House, Mr. Coburn did not run for re-election in 2000. He resumed his medical practice, and in 2002 was appointed by President George W. Bush as a co-chairman of his advisory council on H.I.V. and AIDS, giving him a prominent platform as he prepared to run for the Senate.
Mr. Coburn also wrote a book about his experiences in Congress, Breach of Trust: How Washington Turns Outsiders Into Insiders (2003, with Mr. Hart). In it, he called careerism the central tenet of Congress. Both parties today, he wrote, are ultimately controlled not by ideas, but by the desire to be in control, a posture that creates little motivation for bold change.
In 2004, Mr. Coburn won the Senate seat being vacated by a four-term Oklahoma Republican, Don Nickles. He handily defeated former Representative Brad Carson, a Democrat.
Mr. Coburn continued his conservative fiscal and social voting record, but with far wider public and media attention. He became notorious for using a procedural senatorial privilege, called a hold, with which a single senator could block bills from being voted on by the full Senate.
At first his obstructionist tactics were relatively innocuous. He blocked two 2007 bills honoring the 100th birthday of Rachel Carson and her landmark 1962 book, Silent Spring, which documented the environmental effects of pesticides. Mr. Coburn called the book junk science and the catalyst in the deadly worldwide stigmatization against insecticides, especially DDT.
Later bills blocked by Mr. Coburn included provisions for health care, penalties for child pornography and protections for natural resources. Senate business was dragging to a crawl under the tactical loophole he was exploiting.
In 2008, to expose and embarrass Mr. Coburn, the Senate majority leader, Harry Reid, introduced 35 of the most irresistible-sounding bills together as omnibus legislation. It was a benign collection that almost any senator would be ashamed to vote against: a Mothers Act to relieve postpartum depression, a Protect Our Children Act to thwart internet predators, and a shameless measure to commemorate The Star-Spangled Banner.
Tom Coburn put a hold on the package, which was mocked as the Tomnibus bill. He did not back down. Neither did Senate Democrats.
The struggle lasted two years, but came to a head when he put a hold on a bill to fund the disarming of the Lords Resistance Army, a Ugandan terrorist group that had massacred countless civilians and dragooned children into its ranks. After an 11-day round-the-clock protest outside Mr. Coburns office by people outraged that funds to suppress terrorists were being held up, he relented and the bill passed.
Re-elected in 2010, he pledged not to seek a third term. He left the Senate in early 2015 after retiring for health reasons, but continued to write and speak against government waste and profligate spending.
Thomas Allen Coburn was born in Casper, Wyo., on March 14, 1948, to Orin Wesley and Anita (Allen) Coburn. In Muskogee, where the family settled, his father was an optician who founded Coburn Optical Industries, which made ophthalmic equipment and eyeglass lenses. The company was sold to Revlon for $57 million in 1975, although the elder Mr. Coburn continued as president of the subsidiary. Tom Coburn graduated from Central High School in Muskogee in 1966.
In 1968 he married Carolyn Denton, the 1967 Miss Oklahoma. They had three daughters: Callie, Katie and Sarah, the operatic soprano. He is survived by his wife, his daughters and nine grandchildren.
At Oklahoma State University, Mr. Coburn was an honors student and president of the student business council. He graduated in 1970 with a bachelors degree in accounting. From 1970 to 1978, he was the manufacturing manager of the ophthalmic division of Coburn Optical Industries in Colonial Heights, Va.
After the family business was sold, he attended medical school at the University of Oklahoma and received his medical degree with honors in 1983. He interned at St. Anthony Hospital in Oklahoma City, had a residency at the University of Arkansas Health Education Center in Fort Smith and returned to Muskogee to open his family and obstetrics practice.
He was a deacon of the Southern Baptist Church and participated in medical missions to Haiti in 1985 and Iraq in 1992.
His decision to run for Congress in 1994 was a long shot. He narrowly won, becoming the first Republican to represent Oklahomas Second Congressional District in 73 years.
Mr. Coburn had homes in Muskogee and Tulsa. Besides Breach of Trust, he wrote two books: The Debt Bomb: A Bold Plan to Stop Washington From Bankrupting America (2012, with Mr. Hart) and Smashing the DC Monopoly: Using Article V to Restore Freedom and Stop Runaway Government (2017), about a plan for the states to amend the United States Constitution.
While he never drifted from his conservative convictions, Mr. Coburn forged a friendship in Washington that was as unlikely as it was enduring. Arriving in the Senate together in 2005, he and Barack Obama quickly bonded.
Shortly before he retired, Mr. Coburn said of Mr. Obama: I think hes a neat man. You dont have to be the same to be friends. Matter of fact, the interesting friendships are the ones that are divergent.
Jonathan Martin contributed reporting.
Continued here:
Tom Coburn, the Dr. No of Congress, Is Dead at 72 - The New York Times
- Breast Cancer Is Most Common Cancer In India, 1.38 Million Cases Diagnosed Annually. Know Estimated Incidence By 2030 - ABP Live - November 26th, 2023
- What Is Amyloidosis? All About The Rare Disease That Pervez Musharraf Suffered From - ABP Live - February 8th, 2023
- Autophagic death of neural stem cells mediates chronic stress-induced ... - November 7th, 2022
- Programmed cell death - Wikipedia - November 7th, 2022
- Hematopoietic Stem Cells | Hematopoiesis | Properties & Functions - September 4th, 2022
- Canadian Blood Services Stem Cells for Life - September 4th, 2022
- Devastation over death of schoolgirl, 11, who hoped she was beating cancer - Leicestershire Live - September 4th, 2022
- From optimized stem cell transplants to CAR T cell therapy: Advancing options for cancer, HIV and more - City of Hope - September 4th, 2022
- Scientists unlock the key to immortality in jellyfish - Syfy - September 4th, 2022
- Forge Biologics Reports Positive Clinical Data on Brain Development and Motor Function from the RESKUE Novel Phase 1/2 Gene Therapy Trial in Patients... - September 4th, 2022
- Menin Inhibitors Have Potential to Become the Next Class of Targeted Therapy in AML - Targeted Oncology - September 4th, 2022
- Wanted murder suspect John Belfield believed to still be in the UK as two more arrested over death of Thomas Campbell - The Manc - September 4th, 2022
- Next-day manufacture of a novel anti-CD19 CAR-T therapy for B-cell acute lymphoblastic leukemia: first-in-human clinical study | Blood Cancer Journal... - July 8th, 2022
- Can minds persist when they are cut off from the world? - Livescience.com - July 8th, 2022
- Black Adolescent Young Adults With AML Have Worse Outcomes Vs White Population - Cancer Network - July 8th, 2022
- Akari Therapeutics Announces First Patient to Complete Course of Treatment in the Phase III Part A Clinical Trial of Investigational Nomacopan in... - July 8th, 2022
- How abortion ruling could affect IVF and embryonic research - The Almanac Online - July 8th, 2022
- This Morning viewers 'in tears' after boy meets donor who saved his life - Devon Live - July 8th, 2022
- Alpena detective: 'Good people out there' | News, Sports, Jobs - Alpena News - July 8th, 2022
- 'I miss my best friend': Five-year-old runs 10k to honour girl who died from rare brain tumour - Teesside Live - July 8th, 2022
- Humanigen Announces Peer-Reviewed Publication in Thorax Supporting Early Treatment of Hospitalized COVID-19 Patients with Lenzilumab Guided by... - July 8th, 2022
- Novartis AG, AstraZeneca Plc, and Pfizer Inc Among Leading Companies in the Thyroid Cancer Pipeline Products Market | Globaldata Plc - Yahoo Finance - July 8th, 2022
- A New Strategy Could Turn the Tide in Stem Cell GVHD - Medical Device and Diagnostics Industry - January 17th, 2022
- Vertex type 1 diabetes vs stem cell therapy - The Boar - January 17th, 2022
- Two-Year OS Doubles for Patients With Philadelphia-Positive Relapsed ALL After HSCT - AJMC.com Managed Markets Network - January 17th, 2022
- Nowakowski Considers CD19 Therapy in Transplant-Ineligible DLBCL - Targeted Oncology - January 17th, 2022
- Psaki demolishes Doocy with stats as he tries to claim covid now an illness of the vaccinated - newsconcerns - January 17th, 2022
- Doctors and Researchers Probe How COVID-19 Attacks the Heart - The Scientist - January 17th, 2022
- Who does donated blood that's direly needed help? - WTOP - January 17th, 2022
- Places Where Omicron is Most Contagious Eat This Not That - Eat This, Not That - January 17th, 2022
- UHN and U of T receive $24-million federal grant for transplant research - News@UofT - January 17th, 2022
- Glycyrrhizic acid ameliorates submandibular gland oxidative stress, autophagy and vascular dysfunction in rat model of type 1 diabetes | Scientific... - January 17th, 2022
- Stem cells in cancer therapy: opportunities and challenges - January 1st, 2022
- Life After Brain Death: Is the Body Still 'Alive'? | Live ... - January 1st, 2022
- Autologous Adult Stem Cells in the Treatment of Stroke | SCCAA - Dove Medical Press - January 1st, 2022
- Stem Cell Mimicking Nanoencapsulation for Targeting Arthrit | IJN - Dove Medical Press - January 1st, 2022
- Cellular Therapies Fill Unmet Needs in R/R Multiple Myeloma - Targeted Oncology - January 1st, 2022
- Upregulated expression of actin-like 6A is a risk factor | CMAR - Dove Medical Press - January 1st, 2022
- COVID-19 Takes a Toll on People with Blood Cancers and Disorders - Cancer Health Treatment News - January 1st, 2022
- Mental health disorders and heart diseases - Rising Kashmir - January 1st, 2022
- Research breakthrough could mean better treatment for patients with most deadly form of brain tumor - EurekAlert - October 26th, 2021
- European Commission Approves Merck's KEYTRUDA (pembrolizumab) Plus Chemotherapy as Treatment for Certain Patients With Locally Recurrent Unresectable... - October 26th, 2021
- European Commission Selects Humanigen's Lenzilumab as One of the 10 Most Promising Treatments for COVID-19 - Galveston County Daily News - October 26th, 2021
- Everything You Need To Know About COVID Booster Shots - Colorado Times Recorder - October 26th, 2021
- Stem cells and their role in lung transplant rejection - Michigan Medicine - October 5th, 2021
- Losing Your Hair? You Might Blame the Great Stem Cell Escape. - The New York Times - October 5th, 2021
- Will humans ever be immortal? - Livescience.com - October 5th, 2021
- Healthcare Researchers Are Putting HUMAN Immune Systems In Pigs To Study Illnesses-Here's The Tech Behind It - Tech Times - October 5th, 2021
- Why Bezos, Musk, Page and other billionaires want to live forever - New York Post - October 5th, 2021
- Faster healing of wounds can decrease pain and suffering and save lives - ABC 12 News - October 5th, 2021
- U.S. FDA Approves Kite's Tecartus as the First and Only Car T for Adults With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia - Business... - October 5th, 2021
- Skeletons' broken clavicles tell a centuries-old tale of humans and horses - Massive Science - October 5th, 2021
- Environmental Factor - August 2021: Extramural Papers of the Month - Environmental Factor Newsletter - August 4th, 2021
- Role of traumatic brain injury in the development of glioma | JIR - Dove Medical Press - August 4th, 2021
- Targeted Therapeutics Market: Increase in Incidence of Cancer to Drive Global Market - BioSpace - August 4th, 2021
- Accumulation of Regulatory T Cells in Triple Negative Breast Cancer Ca | CMAR - Dove Medical Press - August 4th, 2021
- Novel CAR-T Cell Therapy Produces Early and Deep Responses in Certain Patients with Multiple Myeloma - Curetoday.com - June 7th, 2021
- Autophagy suppresses the formation of hepatocyte-derived cancer-initiating ductular progenitor cells in the liver - Science Advances - June 7th, 2021
- Cancer research: New advances and innovations - Medical News Today - June 7th, 2021
- Fulvestrant Alone Found to be Superior to Venetoclax/Fulvestrant Combo in ER+/HER2- Breast Cancer - Targeted Oncology - June 7th, 2021
- Merck's KEYTRUDA Given After Surgery Reduced the Risk of Disease Recurrence or Death by 32% Versus Placebo as Adjuvant Therapy in Patients With Renal... - June 7th, 2021
- Stem cell study illuminates the cause of an inherited heart disorder | Penn Today - Penn Today - February 14th, 2021
- The race to treat a rare, fatal syndrome may help others with common disorders like diabetes - Science Magazine - February 14th, 2021
- Jasper Therapeutics Announces Positive Data from Phase 1 Clinical Trial of JSP191 as Targeted Stem Cell Conditioning Agent in Patients with... - February 14th, 2021
- The Very First Signs of an Immune Response Have Been Filmed in a Developing Embryo - ScienceAlert - February 14th, 2021
- Arlo's Army needs stem cell donor as mum begs for help to save three-year-old's life - Glasgow Live - February 14th, 2021
- Astellas and Seagen Announce Phase 3 Trial Results Demonstrating Survival Advantage of PADCEV (enfortumab vedotin-ejfv) in Patients with Previously... - February 14th, 2021
- [Full text] Successful Use of Nivolumab in a Patient with Head and Neck Cancer Aft | OTT - Dove Medical Press - February 14th, 2021
- The drug treatments offering the best hope of a way out of the Covid crisis - Telegraph.co.uk - February 14th, 2021
- In the war against Covid, an arsenal of drugs is on the way - Telegraph.co.uk - February 14th, 2021
- Kat Wests husband, Jeff West, sentenced to 16 years in wifes death - AL.com - February 9th, 2021
- Harnessing the Potential of Cell and Gene Therapy - OncLive - February 9th, 2021
- I Survived Cancer, and Then I Needed to Remember How to Live - The Atlantic - February 9th, 2021
- [Full text] Higher Red Blood Cell Distribution Width is a Poor Prognostic Factor f | CMAR - Dove Medical Press - February 9th, 2021
- West Belfast woman to be remembered in special TV documentary - Belfast Live - January 29th, 2021
- UTV documentary tells of young Belfast woman's lasting legacy to promote stem cell donation - The Irish News - January 29th, 2021
- L-MIND Trial Results Show CD19 Antibody Is Reasonable in R/R DLBCL - Targeted Oncology - January 29th, 2021
- Vertex Announces FDA Clearance of Investigational New Drug (IND) Application for VX-880, a Novel Cell Therapy for the Treatment of Type 1 Diabetes... - January 29th, 2021
- If I Have Cancer, Dementia or MS, Should I Get the Covid Vaccine? - Kaiser Health News - January 29th, 2021
- Experimental taphonomy of organelles and the fossil record of early eukaryote evolution - Science Advances - January 29th, 2021